Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Live Q&A - 24 September 2020 - 15:45-16:45
Date
14 Sep 2020Session
Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncologyPresenters
Markus MöhlerAuthors
M. MöhlerAuthor affiliations
- Universitätsmedizin Mainz, 55131 - Mainz/DE
Resources
Resources from the same session
Welcome and Introduction
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Current status of I-O for the treatment of metastatic colorectal cancer
Presenter: Sara Lonardi
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
I-O for upper GI cancers: Where are we today?
Presenter: Elizabeth Smyth
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Case study workshop: Expert insights into I-O therapy for GI cancers
Presenter: Elizabeth Smyth
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Summary and close
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.